Skip to main content

Table 1 The clinical and biochemical / hormonal data in women with polycystic ovary syndrome (PCOS) patients and healthy controls

From: Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients

Variable Women with PCOS (n _ 46) Healthy controls (n _ 28) P
Age, years 21.97 ± 4.19 23.42 ± 4.70 0.17
BMI, kg/m2 24.50 ± 5.51 23.77 ± 4.91 0.56
Waist/hip ratio 0.81 ± 0.73 0.81 ± 0.63 0.97
Fasting insulin, μ IU/ml 13.84(4.03-47.97) 10.35(2.1-25.8) 0.007
Fasting glucose, mg/dl 91.23 ± 8.24 89.07 ± 9.85 0.31
HOMA-IR 3.21(0.38-12.25) 2.23(0.47-6.43) 0.011
Total cholesterol, mg/dl 173.63 ± 29.41 154.46 ± 26.74 0.006
Triglyceride, mg/dl 111.65 ± 52.80 78.53 ± 30.30 0.002
HDL-C, mg/dl 51.47 ± 12.36 50.78 ± 11.68 0.81
LDL-C, mg/dl 99.68 ± 26.60 87.62 ± 22.58 0.04
hsCRP, mg/L 1.33(0.15-15.8) 0.97(0.15-9) 0.35
TSH, μ IU/ml 2.19 ± 0.96 1.72 ± 0.81 0,03
FSH, m IU/ml 5.49 ± 1.71 5.98 ± 1.86 0.25
LH, m IU/ml 5.69 ± 1.84 5.63 ± 2.25 0.90
Estradiol, pg/ml 40.68 ± 23.25 71.12 ± 42.00 <0.001
Free testosterone,pg/ml 2.99 ± 1.09 1.58 ± 0.51 <0.001
Total testosterone, ng/ml 0.56 ± 0.27 0.41 ± 0.14 0.01
17-OHprogesterone,ng/ml 1.45 ± 0.60 0.98 ± 0.57 0.002
DHEAS, μq/dl 292.60 ± 138.54 175.28 ± 81.63 <0.001
CIMT, mm 0.42 ± 0.056 0.37 ± 0.061 <0,001
HFABP, ng/dl 39.87(22.88-135.12) 35.64(17.86- 79.97) 0.419
  1. BMI body mass index, HOMA-IR homeostasis model assessment insulin resistance index, HDL-C high density lipoprotein cholesterol, LDL-C LOW density lipoprotein cholesterol, hs-CRP high-sensitive C- reactive protein, TSH thyroid stimulating hormone, FSH follicle-stimulating hormone, LH luteinizing hormone, DHEAS dehydroepiandrosterone sulfate, CIMT carotid intima media thickness, HFABP heart fatty acid binding protein.